Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand mpox (formerly monkeypox), its symptoms, transmission, and the crucial importance of combating stigma, especially within the LGBTQ+ community, drawing lessons from the HIV/AIDS crisis.
The mpox virus, formerly known as monkeypox, has brought to the forefront critical discussions about public health, disease transmission, and the persistent issue of stigma, particularly within the LGBTQ+ community. The World Health Organization (WHO) made the significant decision in November 2022 to change the name from 'monkeypox' to 'mpox' to mitigate the risk of stigmatization and other negative associations. This article aims to provide a comprehensive understanding of mpox, its history, symptoms, transmission, and crucially, how messaging surrounding the virus can either perpetuate or combat harmful stereotypes, drawing parallels with the HIV/AIDS crisis of the past.
The mpox virus was first identified in laboratory apes as early as 1958. Its emergence as a significant public health concern led the World Health Organization to declare a Public Health Emergency of Concern on July 23, highlighting its potential as a global threat. This declaration underscored the need for a coordinated worldwide response. The history of public health crises, however, is often intertwined with societal biases and delayed responses, as seen during the HIV/AIDS epidemic.
The 1980s and 1990s witnessed the devastating HIV/AIDS crisis, a period that disproportionately affected gay and bisexual men. This epidemic was marred by widespread stigma, misinformation, and a slow, often inadequate, public health response. The initial naming of the disease, such as 'Gay Related Immune Deficiency' (GRID) or colloquially 'gay cancer,' directly linked it to the LGBTQ+ community, fostering fear and discrimination. Health campaigns, like the UK's 'AIDS: Don’t Die Of Ignorance,' were launched years after the first cases emerged globally, contributing to a significant loss of life. By 1990, over 100,000 people in the US had died from AIDS-related illnesses. The activism within the LGBTQ+ community during this period was instrumental in raising awareness and demanding action, a legacy that continues to influence contemporary health advocacy.
Mpox is a viral disease caused by the mpox virus, a member of the Orthopoxvirus genus, which also includes the virus that causes smallpox. The symptoms typically include fever, swollen lymph nodes, and a widespread rash. While similar to smallpox, mpox symptoms are generally milder. A physician and LGBTQ+ advocate, writing under the handle @thatgaydoctor, shared their personal experience with mpox, describing symptoms such as swollen lymph nodes, fatigue, chills, and a distinctive rash. They noted that treatment is primarily supportive care, focusing on managing symptoms and lesions, unless the individual is immunocompromised. There is no specific cure for the virus itself, but pain medication and wound care are essential for managing the lesions.
With the recent uptick in mpox cases, particularly affecting individuals assigned male at birth who have sex with other individuals assigned male at birth, there are significant concerns about the potential for renewed stigma against the LGBTQ+ community. The historical context of the HIV/AIDS crisis, coupled with existing societal biases against Queer sexual practices and a lack of comprehensive information, has understandably created fear and anxiety within the community. The messaging surrounding mpox is therefore crucial. Inaccurate or fear-mongering communication can easily echo the harmful narratives of the past, leading to discrimination and hindering effective public health efforts. Conversely, clear, empathetic, and accurate messaging can help to de-stigmatize the disease and encourage necessary preventive measures and seeking medical care.
The Biden-Harris Administration launched its mpox vaccine strategy in June 2022, signaling a commitment to addressing the outbreak. However, the effectiveness of these measures is closely tied to how the information is disseminated. It is vital that public health campaigns are inclusive, fact-based, and sensitive to the experiences of affected communities. Efforts to combat misinformation, such as those undertaken by health advocates sharing accurate information on social media, are essential. Furthermore, ensuring equitable access to testing, vaccination, and treatment is paramount. A recent legal challenge in Texas, questioning the mandatory coverage of HIV prevention drugs under the Affordable Care Act based on religious beliefs, highlights the ongoing societal tensions and the need for vigilance against discrimination in healthcare access.
Preventing the spread of mpox involves understanding its transmission routes, which primarily occur through close, personal, skin-to-skin contact with the rash of someone who has mpox. Avoiding close contact with individuals who have mpox, practicing good hygiene, and getting vaccinated if you are at risk are key preventive measures. If you develop symptoms consistent with mpox, such as a new rash or flu-like symptoms, it is important to consult a healthcare professional promptly. Early diagnosis and management can help prevent complications and reduce the risk of transmission.
While mpox has been a global concern, its impact and the public health response in India require specific attention. Understanding the virus, its symptoms, and transmission is the first step. It is crucial for healthcare providers and public health organizations in India to adopt sensitive and accurate communication strategies that avoid stigmatizing any particular community. Promoting awareness about mpox through reliable sources, encouraging safe practices, and ensuring accessible healthcare services are vital. The lessons learned from past epidemics globally, including the HIV/AIDS crisis, should inform India's approach to mpox, emphasizing empathy, inclusivity, and evidence-based public health interventions. Open dialogue about sexual health, without judgment, is essential for fostering trust and encouraging individuals to seek help when needed.
Mpox is the new, preferred name for the disease formerly known as monkeypox. The World Health Organization (WHO) changed the name in November 2022 to reduce stigma and negative associations.
Mpox is primarily transmitted through close, personal, skin-to-skin contact with the rash, scabs, or body fluids of an infected person. It can also spread through touching contaminated materials like clothing or bedding, and through respiratory secretions during prolonged face-to-face contact.
Common symptoms include fever, swollen lymph nodes, headache, muscle aches, backache, and a characteristic rash that may appear within 1 to 3 days after the fever starts. The rash often begins on the face and then spreads to other parts of the body, including the genitals.
Yes, there are vaccines available for mpox. The JYNNEOS vaccine is approved for preventing mpox and smallpox. Vaccination is recommended for individuals who are at higher risk of exposure.
There is no specific cure for mpox, but treatments are available to manage symptoms and complications. Antiviral medications may be used in some cases, particularly for individuals with severe illness or those who are immunocompromised. Supportive care, including pain relief and wound care for lesions, is also important.
Stigmatizing language can create fear, discrimination, and shame, which can discourage people from seeking medical care, testing, or vaccination. It can also lead to social isolation and harm for affected individuals and communities. Learning from the past, such as the HIV/AIDS epidemic, highlights the negative consequences of stigma and the importance of using accurate, respectful, and inclusive language.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Understand the peripheral blood smear test for malaria diagnosis, its procedure, and what results mean for patients.
April 20, 2026
Discover how specialized staining techniques, like Giemsa, are crucial for accurately diagnosing Leishmaniasis, identifying the parasite, and guiding timely treatment. Understand this key diagnostic approach.
April 20, 2026
Understand the peripheral blood smear test for malaria diagnosis, its procedure, and why it's a vital tool in combating this disease.
April 20, 2026